The chemical class of Mi2-α inhibitors is not well-established due to the absence of specific small molecule inhibitors targeting this protein directly. Instead, the focus has primarily been on modulating the protein's function through indirect means, particularly by manipulating the chromatin state. Many of the chemicals listed above are inhibitors of histone deacetylases (HDACs). These inhibitors act by preventing the removal of acetyl groups from histone proteins, a modification that typically relaxes chromatin and allows greater access to DNA for transcription factors and other proteins involved in gene expression, including components of the NuRD complex such as Mi2-α.
The indirect inhibition of Mi2-α involves utilizing small molecules to perturb the broader network of chromatin remodeling and histone modification. The substances listed operate by modifying the epigenetic landscape, which in turn can modulate the activity of Mi2-α as it is a part of the larger complex that relies on the acetylation status of histones to properly engage with the chromatin structure. By maintaining a hyperacetylated state through HDAC inhibition, these compounds maintain an environment that is less conducive to the chromatin remodeling activity that Mi2-α participates in, effectively altering its function in the regulation of gene expression. Additionally, disrupting protein-protein interactions within the NuRD complex through the use of peptidomimetics or inhibiting proteins that recruit Mi2-α to chromatin, such as ZEB1, represents another strategy to modulate Mi2-α activity indirectly.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor; can affect chromatin remodeling by altering acetylation states, thus indirectly affecting Mi2-α. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Histone deacetylase inhibitor; can affect histone and chromatin structure, thereby influencing Mi2-α function. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Histone deacetylase inhibitor; can modify chromatin accessibility and potentially alter Mi2-α activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Histone deacetylase inhibitor; can impact chromatin dynamics and indirectly affect Mi2-α mediated transcription regulation. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Broad-spectrum histone deacetylase inhibitor; can perturb chromatin remodeling activities involving Mi2-α. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Histone deacetylase inhibitor; can alter the epigenetic landscape and indirectly modulate Mi2-α functions. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Histone deacetylase inhibitor; may influence the recruitment and function of Mi2-α within the NuRD complex. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
Histone deacetylase inhibitor; can change transcriptional outcomes by affecting chromatin states, thus impacting Mi2-α. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Natural polyphenol with multiple biological effects; can modulate gene expression and might impact Mi2-α's epigenetic regulation roles. |